Net shares · 365d
+3
3 buy · 0 sell
Net value · 365d
$585
$585 in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
1
3 buy · 0 sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
BIIB Grant·A
Head of Pharm Ops and Tech
$0
10.6K sh
Own New
-
BIIB Buy·P
Head of Pharm Ops and Tech
$585
3 sh · $195.04
Own +0%
-
BIIB Exercise·M
Head of Pharm Ops and Tech
$0
8.7K sh · 3 lots
Own +1359%
-
BIIB Exercise·M
Head of Pharm Ops and Tech
$0
8.7K sh · 3 lots
Own +71%
-
BIIB Other·F
Head of Pharm Ops and Tech
$671.7K
3.3K sh · $201.18 avg · 3 lots
Own -18%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Feb 13, 2026 | BIIB | Grant A | 10.6K | $0 |
| Feb 12, 2026 | BIIB | Buy P | 3 | $585 |
| Feb 6, 2026 | BIIB | Exercise M | 8.7K3 lots | $0 |
| Feb 6, 2026 | BIIB | Exercise M | 8.7K3 lots | $0 |
| Feb 6, 2026 | BIIB | Other F | 3.3K3 lots | $671.7K |
Buy Sell Non-market (grant · exercise · gift)
About Murphy Nicole
This profile aggregates every SEC Form 4 insider transaction reported by Murphy Nicole across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.